Leonard Mazur
2023
In 2023, Leonard Mazur earned a total compensation of $2M as Chief Executive Officer and Executive Chairman at Citius Pharmaceuticals, a 66% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $201,875 |
---|---|
Option Awards | $1,304,238 |
Salary | $475,000 |
Total | $1,981,113 |
Mazur received $1.3M in option awards, accounting for 66% of the total pay in 2023.
Mazur also received $201.9K in non-equity incentive plan and $475K in salary.
Rankings
In 2023, Leonard Mazur's compensation ranked 531st out of 2,978 executives tracked by ExecPay. In other words, Mazur earned more than 82.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 531 | 82nd |
Manufacturing | 304 | 81st |
Chemicals And Allied Products | 211 | 77th |
Drugs | 208 | 76th |
Pharmaceutical Preparations | 130 | 79th |
Mazur's colleagues
We found two more compensation records of executives who worked with Leonard Mazur at Citius Pharmaceuticals in 2023.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018